BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11586094)

  • 1. Expression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters.
    Merati K; said Siadaty M; Andea A; Sarkar F; Ben-Josef E; Mohammad R; Philip P; Shields AF; Vaitkevicius V; Grignon DJ; Adsay NV
    Am J Clin Oncol; 2001 Oct; 24(5):447-52. PubMed ID: 11586094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclooxygenase-2 and vascular endothelial growth factor in pancreatic tumors.
    Aoki T; Nagakawa Y; Tsuchida A; Kasuya K; Kitamura K; Inoue K; Ozawa T; Koyanagi Y; Itoi T
    Oncol Rep; 2002; 9(4):761-5. PubMed ID: 12066205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors.
    Kokawa A; Kondo H; Gotoda T; Ono H; Saito D; Nakadaira S; Kosuge T; Yoshida S
    Cancer; 2001 Jan; 91(2):333-8. PubMed ID: 11180079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in pancreatic adenocarcinoma: correlation with microvessel density.
    Kasper HU; Wolf H; Drebber U; Wolf HK; Kern MA
    World J Gastroenterol; 2004 Jul; 10(13):1918-22. PubMed ID: 15222037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas.
    Niijima M; Yamaguchi T; Ishihara T; Hara T; Kato K; Kondo F; Saisho H
    Cancer; 2002 Mar; 94(5):1565-73. PubMed ID: 11920515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas.
    Okami J; Nakamori S; Yamamoto H; Sakon M; Tsujie M; Hayashi N; Nagano H; Dono K; Umeshita K; Ishikawa O; Ohigashi H; Monden M
    J Exp Clin Cancer Res; 2002 Dec; 21(4):569-76. PubMed ID: 12636104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of prognostic effect of Cox-2 expression in primary breast cancer on short-term follow-up.
    Kelly LM; Hill AD; Kennedy S; Connolly EM; Ramanath R; Teh S; Dijkstra B; Purcell R; McDermott EW; O'Higgins N
    Eur J Surg Oncol; 2003 Nov; 29(9):707-10. PubMed ID: 14602487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical analysis of cyclooxygenase (COX)-2 expression in pancreatic endocrine tumors: association with tumor progression and proliferation.
    Ohike N; Morohoshi T
    Pathol Int; 2001 Oct; 51(10):770-7. PubMed ID: 11881729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion.
    Ryu HS; Chang KH; Yang HW; Kim MS; Kwon HC; Oh KS
    Gynecol Oncol; 2000 Mar; 76(3):320-5. PubMed ID: 10684704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
    Molina MA; Sitja-Arnau M; Lemoine MG; Frazier ML; Sinicrope FA
    Cancer Res; 1999 Sep; 59(17):4356-62. PubMed ID: 10485483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.
    Giannopoulos G; Pavlakis K; Parasi A; Kavatzas N; Tiniakos D; Karakosta A; Tzanakis N; Peros G
    Anticancer Res; 2008; 28(3B):1875-81. PubMed ID: 18630474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.
    Khuri FR; Wu H; Lee JJ; Kemp BL; Lotan R; Lippman SM; Feng L; Hong WK; Xu XC
    Clin Cancer Res; 2001 Apr; 7(4):861-7. PubMed ID: 11309334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas].
    Wang HX; Chen QK
    Ai Zheng; 2003 Jun; 22(6):649-52. PubMed ID: 12948419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Holden J; Davis M; Zempolich K; Murphy KJ; Dodson M
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1213-7. PubMed ID: 11286825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ERRP in normal and neoplastic pancreata and its relationship to clinicopathologic parameters in pancreatic adenocarcinoma.
    Feng J; Adsay NV; Kruger M; Ellis KL; Nagothu K; Majumdar AP; Sarkar FH
    Pancreas; 2002 Nov; 25(4):342-9. PubMed ID: 12409827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer.
    Kong G; Kim EK; Kim WS; Lee KT; Lee YW; Lee JK; Paik SW; Rhee JC
    J Gastroenterol Hepatol; 2002 Aug; 17(8):914-21. PubMed ID: 12164968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2, MMP-9, and Noguchi classification provide additional prognostic information about adenocarcinoma of the lung. A study of 117 patients from Brazil.
    Yamaguchi NH; Lichtenfels AJ; Demarchi LM; da Silva AP; Garippo AL; Alves VF; Michelin C; Azevedo PM; Moya T; Takagaki T; Saldiva PH; Vollmer RT; Capelozzi VL
    Am J Clin Pathol; 2004 Jan; 121(1):78-86. PubMed ID: 14750244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 expression associated with severity of PanIN lesions: a possible link between chronic pancreatitis and pancreatic cancer.
    Albazaz R; Verbeke CS; Rahman SH; McMahon MJ
    Pancreatology; 2005; 5(4-5):361-9. PubMed ID: 15980665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
    Okami J; Yamamoto H; Fujiwara Y; Tsujie M; Kondo M; Noura S; Oshima S; Nagano H; Dono K; Umeshita K; Ishikawa O; Sakon M; Matsuura N; Nakamori S; Monden M
    Clin Cancer Res; 1999 Aug; 5(8):2018-24. PubMed ID: 10473081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications].
    Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L
    Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.